Tuesday, 17 September 2019

China News

  • EntreMed gets funding from China investors

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2013

    Singapore: EntreMed, a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, has received commitments from two China-based investors, including institut...Read more

  • China Nepstar disposes 40% equity ownership in Yunnan Jianzhijia

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: China Nepstar Chain Drugstore has completed the sales of its 40 percent equity ownership in Yunnan Jianzhijia Chain Drugstore Ltd. (JZJ) to Yunnan Jianzhijia Holding (JZJ Holding...Read more

  • China vigilant on drug price policy

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: A team of China's National Health and Family Planning Commission (NHFPC) led by Mr Li Xi, head, Permanent Discipline Inspection Group, China, have visited sites in Jiangsu, Anhui...Read more

  • Parexel opens its 6th office in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2013

    Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client demand for a broad range of clinical development capabilities in the count...Read more

  • ShangPharma celebrates 10 years with Eli Lilly

    China |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

    Singapore: ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, celebrated the 10th anniversary of its partnership with Eli Lilly. "I a...Read more

  • Top 20 APAC Country Analysis: Korea

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 20 Jun, 2015

    Singapore: South Korea is the fourth largest contributor to the lifescience market in the region. • Korean Ministry of Food and Drug Safety (MFDS) stated that medicine exports of th...Read more

  • A time to rethink talent management

    China |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

            Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It tested their skills to keep pace with the high level of investment and ...Read more

  • John Crowley is Charles River's CAO

    China |  Influencers | By BioSpectrum Bureau  | 0 Comment | 27 Sep, 2013

    Singapore: Charles River Laboratories has appointed Mr John Crowley to the role of corporate senior VP, corporate controller and chief accounting officer (CAO), effective September 30, 2013...Read more

  • Zhejiang Medicine, Ambrx to develop antibody drug conjugate for breast cancer

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced interna...Read more

  • Innovative way to meet the global HSA requirement

    China |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2012

    Human serum albumin (HSA), a blood protein that is widely used in drug and vaccine production, is in high demand around the world. The primary source of the HSA is donated human blood, whic...Read more

  • BGI-Shenzhen extends tender offer for Complete Genomics

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: BGI-Shenzhen (BGI) announced that it, through its wholly owned subsidiary Beta Acquisition, has extended its all cash tender offer to purchase all outstanding shares of common s...Read more

  • China Botanic gets warning from NYSE

    China |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

    Singapore: China Botanic Pharmaceutical (formerly Renhuang Pharmaceuticals) received a warning letter from the NYSE MKT highlighting that the company is not in compliance with Section 803...Read more

  • New strategies drive growth in Yunnan Baiyao

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Yunnan Baiyao made new strategies for 2011 and the year recorded relocation, expansion of the company's business development space, well-organized production and management, and optimizatio...Read more

  • Biostar signs another $3 mn military contract within a month

    China |  News | By BioSpectrum Bureau  | 0 Comment | 18 Oct, 2012

    Singapore: China-based Biostar Pharmaceuticals signed a one-year agreement, valued at approximately $3.0 million, to manufacture and supply Xijing Hospital with five additional drugs. Spec...Read more

  • Chinese to get first-ever oral rotavirus vaccine

    China |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2013

    Singapore: The not-for-profit organization, International Medica Foundation, that works towards the development of a safe, effective and affordable rotavirus vaccine, will now be providing ...Read more

  • Xiangxue Pharma acquires rights for Kinex KX02

    China |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Kinex Pharmaceuticals executed a license agreement with Xiangxue Pharmaceuticals granting Xiangxue Pharmaceuticals exclusive rights to Kinex's KX02 for all oncology indications i...Read more

  • Chinese, Hong Kong scientists map H7N9 risk infection

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 May, 2013

    Singapore: A map of avian influenza (H7N9), comprising of bird migration patterns and estimations of poultry production and consumption, which can be used to determine future risk and advis...Read more

  • Mr George Baeder, Quintiles: Companies will fail to leverage on what China has to offer in 2013

    China |  Opinion | By BioSpectrum Bureau  | 0 Comment | 25 Dec, 2012

    China's role in the global drug industry will fundamentally change; most companies will fail to capitalize on this opportunity. Prepare for the world of traditional Western drug development...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls